Genetic differences may explain the greater risk for prostate cancer among Caucasian men compared with Hispanic men, which could help clinicians predict who is more likely to develop the disease, according to a paper published in the May 15, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Studying thousands of patients, Japanese researchers have found a strong link between tooth loss and increased risk of three cancers "“ esophageal, head and neck, and lung. They suggest that preservation of teeth may decrease risk of developing these diseases.
American Association for Cancer Research (AACR) Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) is the 2008 recipient of the George Washington University Cancer Institute's Distinguished Public Service Award, presented to an individual who has provided outstanding public leadership in cancer healthcare and public policy. Foti was honored during the Fifth Annual GW Cancer Institute Gala on May 3, 2008 at the National Building Museum in Washington, D.C.
Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, "stuck" between diagnoses "“ they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution.
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer.
Irregular molecules in the lining of the mouth, the saliva, the fallopian tube or the bladder can identify early stage cancer, according to research presented today at the 2008 Annual Meeting of the American Association for Cancer Research, April 12 "“ 16. Scientists who hope to apply basic knowledge to medical practice are developing tests that diagnose, predict or monitor cancer risks without invasive tissue sampling.
As potential cancer therapies proliferate, researchers and clinicians are striving to measure their effectiveness and to more accurately predict which patients will receive the most benefit. At the American Association for Cancer Research 2008 Annual Meeting, April 12-16, 2008, researchers present data on a new role for MRI in brain cancer, how doctors can more effectively measure response to commonly used cancer drugs, and a unique method for predicting the risk of breast cancer spread.
As our population ages and senior citizens become a larger demographic, cancer researchers are focusing on the links between aging and cancer. Studies presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12 "“ 16, highlight the biological aspects of aging that are key to greater risk and poorer prognosis, and surgical outcomes.
Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. As scientists learn more their cancer-initiating properties, stem cells are emerging as potential therapeutic targets for many types of cancers. Studies presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, report stem cell discoveries related to pancreatic, bladder, ovarian, and breast cancer, and glioma.
As promising cancer therapies and drugs emerge, researchers strive to find ways to deliver them to patients with minimal side effects. At the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, researchers report that therapies delivered by "trojan horse" peptides and through the use of nanotechnology may enhance the effectiveness of cancer treatment.
Research reported at the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, suggests that poorer outcomes for breast cancer and prostate cancer among minorities may be due to biologic factors. In addition, researchers present a new theory on why a recent decline in breast cancer rates was less pronounced among African-American women, and offer data on a relatively simple means of reducing racial disparities in breast cancer care.
New drug compounds, and old ones put to new use, offer doctors and patients new hope for treating and preventing cancer. Studies presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, show promise and progress against brain, colorectal, rectal and ovarian cancers and lymphoma.
Researchers are directing the body's immune system to shrink tumors and prevent new ones from forming. Data presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, detail how cellular strategies and new vaccines are changing the cancer treatment landscape.
Tapping into a growing body of knowledge about the origins and progression of cancer, researchers are now developing and testing new preventive therapies to stop it in its tracks. At the 2008 Annual Meeting of the AACR, April 12-16, researchers present data on the preventive effects of celecoxib and atorvastatin and vitamin D in colorectal, prostate and breast cancer, respectively, and the relationship between diet, metabolism and the development of pancreatic cancer.
A combination of the targeted agent difluoromethylornithine (DFMO) at a low dose and sulindac, a non-steroidal anti-inflammatory drug (NSAID), reduces the risk of recurrent colorectal adenomas, an early sign of colon cancer, by up to 95 percent with less toxicity than with chemotherapy, researchers report.
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report.
Reinforcing its commitment to supporting high-quality cancer research, the Kirk A. and Dorothy P. Landon Foundation have again partnered with the American Association for Cancer Research (AACR) to create two new funding opportunities, the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research and the Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research. These awards, each offering a two-year $100,000 grant, will support the work of promising cancer researchers focusing on cancer prevention and international collaboration, respectively.
A healthy diet and lifestyle protect against a wide range of diseases, and new research presented at the AACR 2008 Annual Meeting, April 12-16, shows that cancer is no exception. Researchers demonstrate how excessive alcohol drinking could lead to an increased risk of breast cancer, how consuming too many calories may increase one's risk for melanoma, and why with folic acid, timing is everything for colon cancer prevention.
Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, enabling more precise and effective treatment. At the 2008 Annual Meeting of the AACR, researchers present data on new biomarkers that can predict response to well known treatments for breast cancer, pediatric neuroblastoma, and kidney and non-small cell lung cancer.
The American Association for Cancer Research (AACR) is offering teleconference lines for media interested in participating in the press briefings scheduled during its Annual Meeting 2008, April 12-16 in San Diego, CA. Following the briefings, the phone lines will be opened for "question and answer" sessions
Tyler E. Jacks, Ph.D., of the Massachusetts Institute of Technology (MIT) has been named president-elect of the American Association for Cancer Research (AACR). He succeeds Raymond N. DuBois, M.D., Ph.D., provost and executive vice president for academic affairs at The University of Texas M. D. Anderson Cancer Center, who will become president.
Cutting-edge breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the San Diego Convention Center April 12-16 for the 2008 Annual Meeting of the American Association for Cancer Research. Key data presented at the meeting will include late-breaking clinical trial findings related to high-profile, potentially life-saving cancer therapies in the pipeline.
American Association for Cancer Research Secures Official Congressional Designation: In a bipartisan show of support for cancer research, the U.S. Congress has declared May as National Cancer Research Month. The American Association for Cancer Research (AACR) secured resolutions from the U.S. Senate and U.S. House of Representatives to raise awareness of the critical advances in cancer research made by its 27,000 members, and its efforts to ensure a secure future for continued progress against a group of diseases which strike half of all men and one in three women.
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research¸ a journal of the American Association for Cancer Research.
Minorities in Cancer Research (MICR), a 3,000-member group within the American Association for Cancer Research (AACR), has selected the winners of two scholar awards for scientists working in underrepresented areas of the cancer research community.
Harald zur Hausen, D.Sc., M.D, internationally recognized for his research demonstrating the role of human papillomavirus as the etiological agent of cervical cancer, will receive the American Association of Cancer Research Award for Lifetime Achievement in honor of his life's work devoted to the study of the viruses and cancer.
Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
A compound found in soybeans almost completely prevented the spread of human prostate cancer in mice, according to a study published in the March 15 issue of Cancer Research, a journal of the American Association for Cancer Research.
To foster interest in cancer research careers among the next generation of young scientists, the AACR will provide an opportunity for 10 undergraduate students to experience the field first hand at its Annual Meeting 2008 through the AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students.
World-class cancer researchers whose science has significantly contributed to progress in the fight against cancer will be recognized April 12-16, 2008, by the American Association for Cancer Research (AACR) at its 2008 Annual Meeting at the San Diego Convention Center in San Diego, Calif.
The AACR Annual Meeting features the latest cutting-edge findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing cancer.
Women whose breast cancer came back after treatment had almost twice as much estrogen in their blood than did women who remained cancer-free "“ despite treatment with anti-estrogen drugs in a majority of the women "“according to researchers in a study published in the March issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
A concentrated extract of freeze dried broccoli sprouts cut development of bladder tumors in an animal model by more than half, according to a report in the March 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. Their study is published in the March 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Scientists whose discoveries have led to fundamental advances in the science and treatment of cancer are the recipients of two prestigious international prizes offered by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research (AACR).
Axel Ullrich, Ph.D., is the recipient of the 2008 Pezcoller Foundation-AACR International Award for Cancer Research for his pioneering work in the translation of genomics-based discoveries into novel approaches for cancer therapy. Ullrich is the Director of Molecular Biology at the Max Planck Institute of Biochemistry in Martinsried, Germany, and is a renowned expert in gene technology and one of the most frequently cited cancer scientists in the area of signal transduction research.
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA (prostate specific antigen), a potential diagnostic indicator of prostate cancer.
FOREMOST INTERNATIONAL MEETING HIGHLIGHTS BREAKTHROUGHS IN CANCER RESEARCH
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio and the American Association for Cancer Research (AACR) announced today a collaboration for the future of the San Antonio Breast Cancer Symposium (SABCS).
How do the lifestyle choices we make affect our chances of developing cancer? Today, at the American Association for Cancer Research's Sixth Annual International Conference on Frontiers in Cancer Prevention Research, being held from December 5 to 8 in Philadelphia, Pennsylvania, researchers will present some answers to questions regarding daily decisions in diet, exercise, smoking and other lifestyle factors.
During this holiday season with its tempting bounty of edible delights, new research presented at the AACR Frontiers in Cancer Prevention Research conference calls attention to the role of the expanding American waistline in health and medicine.
The next cancer-fighting therapeutic could be growing in your garden, according to research presented today, at the American Association for Cancer Research's Sixth Annual International Conference on Frontiers in Cancer Prevention Research, being held from December 5 to 8 in Philadelphia, Pennsylvania.
The age-old refrain, "Eat your vegetables!" gets scientific support as researchers present the latest findings on cancer prevention at the American Association for Cancer Research's Sixth Annual International Conference on Frontiers in Cancer Prevention, being held December 5 "“ 8 in Philadelphia, Pennsylvania.
Medical research has revealed much about cancer prevention, but is the information reaching all Americans, and are they acting on it? Today, at the AACR's Sixth Annual International Conference on Frontiers in Cancer Prevention Research, researchers explore the question of how best to translate cancer prevention science into public health policy.
In response to the growing body of research in the field of cancer prevention, the American Association for Cancer Research (AACR) announces the launch of a major peer-reviewed scientific journal, Cancer Prevention Research, and invites submissions of papers. This important new journal is the first in the world dedicated exclusively to cancer prevention, from preclinical research to clinical trials.
Scientists from the National Cancer Institute are looking into the racial and ethnic differences in the biology of breast cancer tumors and are presenting their findings this week at the American Association for Cancer Research conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, being held November 27-30 in Atlanta.
Researchers based at Tulane University report the discovery of biological markers of prostate cancer which are involved in the growth of tumor cells, shedding light on the genetic basis for the prostate cancer burden faced by African-American men.
Cancer affects whole communities of people with similar genetic heritage and cultural behaviors, yet medical researchers often have trouble uncovering data on minority populations and promoting changes that could improve health. That is why many researchers have begun to collaborate directly with community groups.
Women living in the inner city have difficulty meeting dietary goals that could help prevent cancer, according to a report from Johns Hopkins University researchers. In a study of African-American women living in public housing within Washington, D.C., the researchers found that the majority met one "“ or none "“ of five dietary goals suggested to reduce the risk of developing cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right